DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Cholangitis and intra-abdominal sepsis

Essential points for quick revision.

!
Sepsis with an uncontrolled abdominal source

Hypotension, altered consciousness, rising lactate, oliguria or peritonism with biliary or abdominal infection signals time-critical organ dysfunction and possible obstruction or perforation.

Action: Use ABCDE, obtain cultures and lactate without delaying therapy, give guideline-concordant intravenous antimicrobials and fluids, and involve surgical, gastroenterology, radiology and critical-care teams immediately for source control.

Synopsis

Recognise biliary and intra-abdominal sepsis early, stabilise organ dysfunction, choose anatomy-directed imaging and achieve timely endoscopic, radiological or surgical source control.

  • Acute cholangitis is infection behind an obstructed biliary tree; antibiotics cannot reliably sterilise a pressurised system without drainage.
  • Charcot triad is fever, jaundice and right upper-quadrant pain, but its absence does not exclude cholangitis.
  • Take blood cultures before antibiotics when this does not delay treatment; bacteraemia is common and guides de-escalation.

Key red flags

Hypotension, rising lactate, confusion or oliguria indicates sepsis-related organ dysfunction.

Biliary inflammatory syndrome

Fever or rigors, jaundice and right upper-quadrant or epigastric pain support cholangitis, although older or immunocompromised adults may lack the full triad.

Investigation priorities

01
Blood cultures before antimicrobialsFirst step

Identify bacteraemia and susceptibility while preserving diagnostic yield.

Management branches

RESUSCITATETreat sepsis while defining source

Biliary or intra-abdominal infection is accompanied by abnormal physiology or organ dysfunction.

  1. Use ABCDE, measure lactate and glucose, secure intravenous access, monitor urine output and give oxygen and balanced crystalloid according to physiology.
  2. Obtain blood cultures promptly and begin intravenous antimicrobials within the sepsis pathway, adjusted for allergy, renal function, recent cultures and healthcare exposure.

Key medicines

Co-amoxiclav intravenous regimenGive 1.2 g intravenously every eight hours only when the local intra-abdominal guideline selects it, with renal adjustment as required.
Cefuroxime plus metronidazoleWhere locally recommended, give cefuroxime 1.5 g intravenously every eight hours plus metronidazole 500 mg intravenously every eight hours.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom